AI Stock Picks — S&P 500

Thursday, October 15, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Optimistic  Normal choppiness · VIX 16.6

Breadth is broadly positive with a large cluster of S&P 500 names posting strong sustained 5-day and 30-day gains, led by healthcare/managed-care and mega-cap payments/software names trading within a few percent of their 52-week highs. Softness is concentrated in regional banks, brokers, and several semiconductor names that have pulled back sharply over the last week despite decent 30-day returns, suggesting rotation rather than broad weakness.

Healthcare and managed-care rebound (insurers, pharma, distributors) with multiple names near 52-week highsMega-cap payments/software 'quality compounders' (Visa, Mastercard, Microsoft) trading at or near all-time highsTravel and leisure recovery (hotels) showing multi-week momentumRotation pressure on regional banks, brokers, and parts of semiconductors despite index-level strength

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 3
0%
58 · 141.6%
141.6% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 GILD SKIP — $159.36 → $167.54
stop $147.57
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 UNH SKIP — $410.21 → $431.44
stop $377.80
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#3 WMT SKIP — $118.33 → $124.44
stop $110.99
 Position cap reached — 58 of 20 slots in use.

Already open: WDAY (to Oct 18), LGEN.L (to Oct 21), SSE.L (to Oct 21), IAG.L (to Oct 22), AAPL (to Oct 22), KGF.L (to Oct 23), DHR (to Oct 24), DCC.L (to Oct 25), PFE (to Oct 28), DPLM.L (to Oct 28), SMIN.L (to Oct 28), ABDN.L (to Oct 30) … and 46 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
18 picks
Blaze
5 picks
Nova
No picks
None of the 19 candidates had a company-specific news catalyst (product launch, approval, contract, upgrade, or earnings beat) within the last 21 days — news data was present for all of them but either empty or limited to generic market-wide stories unrelated to the specific company, which under my framework counts as a genuine negative finding rather than a data gap.
Orion
4 picks
Quinn
16 picks

3 Stock Picks

Diversification filter applied: 2 picks removed due to high same-sector price correlation with a higher-ranked pick (LLY, AMGN), avoiding concentrated sector exposure.
#1 GILDGilead Sciences, Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 55%

Gilead makes antiviral and cancer medicines and recently hit an all-time high. The stock's momentum is strong without being overheated, and it's comfortably beating the overall market. The main risk is that much of the move has already happened, so a pause is possible, especially with an earnings report coming inside the window.

Stop-loss$147.57-7.4%
Today's price$159.36
Target$167.54+5.1%
Agents estimate: $167.75 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$926 if the stop-loss is hit (-7.4%)
The AI puts the chance of the win case at 55%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price is already pinned to the upper Bollinger Band (159.36 vs. upper band 156.66) with RSI at 68.4, right at the edge of overbought territory — the bull case calls this 'strength' but it leaves little room for further upside before a mean-reversion pullback.
  • The entire +8.93% move is a single-day earnings gap (previous close $146.30 to $159.36); 5-day momentum of 4.8% is actually decelerating versus the 30-day return of 8.93%, suggesting the initial pop is already fading rather than building.
Show the detailed analysis

Calibrated probability: 55% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
59%
+1.1%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
71%
Very High
Nova
—
—
News feed returned only generic market-wide stories (chip sell-off, Micron/Nvidia) with nothing specific to Gilead.
Orion
66%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#2 UNHUnitedHealth Group Incorporated
3/5 Agents Agree  Risk 4/10
Strong conviction · 60%

UnitedHealth runs one of the country's largest health insurance and healthcare-services businesses. It just reported quarter results that beat Wall Street's expectations and raised its full-year profit forecast, and the stock is still well below its 52-week high even after a strong pop, leaving room to keep climbing. The main risk is that some of this good news could already be reflected in the price, and a handful of executives have been selling shares recently.

Stop-loss$377.80-7.9%
Today's price$410.21
Target$431.44+5.2%
Agents estimate: $432.15 (+0.2% vs target)
If you invested $1,000
▲$1,052 if the target hits (+5.2%)
▼$921 if the stop-loss is hit (-7.9%)
The AI puts the chance of the win case at 60%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • OBV divergence is explicitly flagged (ObvDivergence: true) with a deeply negative OBV reading of -109,282,574 — volume is not confirming the price rally, a classic warning that the move lacks real accumulation behind it.
  • RSI at 69.48 is on the threshold of overbought, and the stock is still 11.14% below its 52-week high — the bull framing this gap as 'room to re-rate' ignores that it could equally reflect a market still pricing in skepticism toward the post-earnings pop.
Show the detailed analysis

Calibrated probability: 60% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
60%
+1.3%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
65%
High
Blaze
83%
Very High
Nova
—
—
No news catalyst found at all in the recent feed; earnings already happened 2 days ago with no story confirming the reaction.
Orion
63%
High
Quinn
—
—
On-balance volume is falling even as the price rallies, a divergence suggesting the gains aren't backed by real buying pressure, which pulls the quantitative score down to the floor of the model.

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#3 WMTWalmart Inc.
3/5 Agents Agree  Risk 3/10  ⚠ Conflicting Signals
Moderate conviction · 55%

Walmart is the world's largest retailer, selling everything from groceries to electronics both in stores and online. The company recently raised its full-year profit and sales forecasts on the back of strong e-commerce growth, and its next earnings report isn't due for over a month, so there's no imminent make-or-break event. The stock is also notably below its recent high, giving it room to run, though the price has already climbed quickly and could cool off.

Stop-loss$110.99-6.2%
Today's price$118.33
Target$124.44+5.2%
Agents estimate: $124.63 (+0.2% vs target)
If you invested $1,000
▲$1,052 if the target hits (+5.2%)
▼$938 if the stop-loss is hit (-6.2%)
The AI puts the chance of the win case at 55%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • RSI at 72.22 is clearly in overbought territory (>70), the highest of all three picks, and price is already pressing the upper Bollinger Band (118.33 vs. 116.54) — a stretched setup for a stock the bull thesis calls merely 'strong momentum.'
  • The 50-day SMA ($108.79) sits well below the 200-day SMA ($118.23), meaning price is extended far above its own longer-term trend average, not confirming a durable breakout but a sharp short-term spike.
Show the detailed analysis

Calibrated probability: 55% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.

Trade math

0.8:1
55%
+1.2%
6.4%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
60%
Medium
Blaze
76%
Very High
Nova
—
—
No news catalyst found at all in the recent feed.
Orion
—
—
Retail isn't the sector currently favored by the rotation, and despite decent momentum it remains over 12% below its 52-week high.
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 14, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by November 14, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 503 S&P 500 constituents and short-listed 28 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • AMGNAmgen Inc.Diversification filter
    Scout: 17.4% 30-day and 8.2% 5-day gains with price only 1.4% off its 52-week high — strong sustained momentum in biotech.
    Dropped by diversification filter: 0.73 30-day daily-return correlation with GILD (both in Healthcare).
  • ABBVAbbVie Inc.Dropped at merge
    Scout: Steady 9% 30-day, 5.3% 5-day gains, just 1.6% below its 52-week high; healthcare sector strength continuing.
    Qualified on merit but ranked #12, outside the 5-pick limit for this run.
  • MCKMcKesson CorporationAlready held
    Scout: 10.5% 30-day and 6.8% 5-day gains, trading within 1% of its 52-week high — distributor momentum intact.
    Already held: a position opened 2026-10-14 runs until 2026-11-13 (30 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • TMOThermo Fisher Scientific Inc.Dropped at merge
    Scout: 8.4% 30-day, 6.6% 5-day gains, essentially at its 52-week high — life-sciences tools leadership.
    Qualified on merit but ranked #7, outside the 5-pick limit for this run.
  • GILDGilead Sciences, Inc.Picked #1
    Scout: 8.9% 30-day and 8.3% 5-day gains, less than 1% from its 52-week high — consistent biotech strength.
    Made the final report at #1.
  • LLYEli Lilly and CompanyDiversification filter
    Scout: 11.3% 30-day, 8.1% 5-day gains, only 2.2% off its high — pharma momentum leader continuing higher.
    Dropped by diversification filter: 0.72 30-day daily-return correlation with GILD (both in Healthcare).
  • UNHUnitedHealth Group IncorporatedPicked #2
    Scout: 10.6% 5-day and 9.1% 30-day gains show a strong rebound in managed care after prior weakness.
    Made the final report at #2.
  • HUMHumana Inc.Already held
    Scout: 12.4% 5-day and 9.8% 30-day gains, just 4.7% from its 52-week high — managed-care rally broadening.
    Already held: a position opened 2026-10-12 runs until 2026-11-11 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • VVisa Inc.Already held
    Scout: 6.9% 5-day, 6.8% 30-day gains with price basically at its 52-week high — payments leadership at new-high momentum.
    Already held: a position opened 2026-10-09 runs until 2026-11-08 (25 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MAMastercard IncorporatedAlready held
    Scout: 7.2% 5-day, 7.5% 30-day gains essentially at its 52-week high — mirrors Visa's payments strength.
    Already held: a position opened 2026-10-13 runs until 2026-11-12 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CBOECboe Global Markets, Inc.Dropped at merge
    Scout: 13.8% 30-day and 4.7% 5-day gains reflect sustained exchange-sector momentum.
    Qualified on merit but ranked #11, outside the 5-pick limit for this run.
  • KOThe Coca-Cola CompanyDropped at merge
    Scout: 5.1% 5-day gain with price just 2% off its 52-week high — defensive staple showing fresh strength.
    Qualified on merit but ranked #15, outside the 5-pick limit for this run.
  • KDPKeurig Dr Pepper Inc.Dropped at merge
    Scout: 8.3% 5-day and 7.5% 30-day gains, under 2% from its 52-week high — staples momentum leader.
    Qualified on merit but ranked #9, outside the 5-pick limit for this run.
  • PGThe Procter & Gamble CompanyDropped at merge
    Scout: 7.5% 30-day and 4.7% 5-day gains show renewed strength in a defensive staple.
    Qualified on merit but ranked #16, outside the 5-pick limit for this run.
  • TJXThe TJX Companies, Inc.Already held
    Scout: 16.1% 30-day and 4.2% 5-day gains indicate durable off-price retail momentum.
    Already held: a position opened 2026-10-12 runs until 2026-11-11 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • WMTWalmart Inc.Picked #3
    Scout: 9.5% 30-day and 7.0% 5-day gains show broad-based retail strength.
    Made the final report at #3.
  • ELThe Estée Lauder Companies Inc.Dropped at merge
    Scout: 13.4% 5-day and 11.1% 30-day gains mark a sharp turnaround in beauty/consumer discretionary.
    Qualified on merit but ranked #13, outside the 5-pick limit for this run.
  • MARMarriott International, Inc.Dropped at merge
    Scout: 14.7% 30-day and 7.2% 5-day gains, only 5.9% from its 52-week high — travel recovery momentum.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (55% after calibration)).
  • HLTHilton Worldwide Holdings Inc.Dropped at merge
    Scout: 11.4% 30-day and 6.1% 5-day gains, just 4.2% off its high — hotel sector strength alongside Marriott.
    Qualified on merit but ranked #14, outside the 5-pick limit for this run.
  • MSFTMicrosoft CorporationAlready held
    Scout: 8.7% 30-day gain with price only 2.5% off its 52-week high — mega-cap tech leadership intact.
    Already held: a position opened 2026-10-05 runs until 2026-11-04 (21 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CTASCintas CorporationAlready held
    Scout: 7.2% 30-day and 6.0% 5-day gains within 2.7% of its 52-week high — steady industrial-services momentum.
    Already held: a position opened 2026-10-13 runs until 2026-11-12 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • FDSFactSet Research Systems Inc.Dropped at merge
    Scout: 9.5% 30-day and 5.9% 5-day gains show consistent strength in financial data services.
    Qualified on merit but ranked #10, outside the 5-pick limit for this run.
  • COPConocoPhillipsAlready held
    Scout: 6.0% 5-day bounce with price essentially at its 52-week high — energy name showing renewed strength.
    Already held: a position opened 2026-10-13 runs until 2026-11-12 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AAgilent Technologies, Inc.Dropped at merge
    Scout: 17.3% 30-day gain with price just 0.5% off its 52-week high — strong, sustained life-sciences momentum.
    Only Aria selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 70% raw (60% after calibration)).
  • WSTWest Pharmaceutical Services, Inc.Dropped at merge
    Scout: 5.3% 5-day and 4.8% 30-day gains, under 1% from its 52-week high — steady pharma-services strength.
    Qualified on merit but ranked #8, outside the 5-pick limit for this run.
  • DHRDanaher CorporationAlready held
    Scout: 10.9% 30-day and 6.7% 5-day gains, only 4.4% off its 52-week high — life-sciences tools momentum.
    Already held: a position opened 2026-09-24 runs until 2026-10-24 (10 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • COSTCostco Wholesale CorporationDropped at merge
    Scout: 9.7% 30-day and 4.3% 5-day gains reflect continued strength in a high-quality retailer.
    Qualified on merit but ranked #6, outside the 5-pick limit for this run.
  • METAMeta Platforms, Inc.Dropped at merge
    Scout: 10.6% 30-day gain with price just under 5% off its 52-week high — mega-cap tech momentum remains intact.
    Only Aria selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 70% raw (60% after calibration)).

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.